ArticleJournal of separation science2026
Two Standards-Aided LC-MS Technologies Uncover 30 "Unreported" Compounds in Natural Bear Bile Powder to Add a New Pharmacopoeia Quality-Marker.
Article in Journal of separation science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Natural bear bile powder is a precious traditional Chinese medicine that has a long history of use in clinical practice. The current study analyzed four batches of natural bear bile powder samples (B-1∼B-4) using standards-aided ultra-high-performance liquid chromatography-quadrupole-Orbitrap-mass spectrometry and ultra-performance liquid chromatography coupled with electrospray-ionization quadrupole time-of-flight mass spectrometry. A total of 37 compounds (1-37) were accurately identified, while 30 "unreported" compounds were found in natural bear bile powder for the first time. In particular, two "unreported" isomers (2'-hydroxydaidzein and genistein) were strictly distinguished by means of ΔR.T. matching in chromatographic stick-peak and MS/MS peak matching. The quantification work indicated that taurochenodeoxycholic acid (TCDCA) and its epimer tauroursodeoxycholic acid (TUDCA) had the highest contents in natural bear bile powder. However, TCDCA showed different binding energy towards pregnane X receptor from TUDCA in the molecular docking simulation. Based on the analytical chemistry, molecular docking simulation, and documentary evidence, TCDCA was recommended as a potential Q-marker for pharmacopoeia. The new Q-marker was validated to be feasible by analysis of 11 batches of natural bear bile powder samples (B-5∼B-15), and the specific ratio of TCDCA/TUDCA (0.58∼0.98) can distinguish natural BBP from artificial BBP and other animal biles. All these findings not only lay a foundation for manufacturing technique improvement of artificial natural bear bile powder, but also promote pharmacopoeia to update the quality-control method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.